HomeCompareCGHM vs PFE

CGHM vs PFE: Dividend Comparison 2026

CGHM yields 3.75% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFE wins by $24.1K in total portfolio value· pulled ahead in Year 9
10 years
CGHM
CGHM
● Live price
3.75%
Share price
$25.38
Annual div
$0.95
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.5K
Annual income
$477.28
Full CGHM calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — CGHM vs PFE

📍 PFE pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCGHMPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CGHM + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CGHM pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CGHM
Annual income on $10K today (after 15% tax)
$318.81/yr
After 10yr DRIP, annual income (after tax)
$405.69/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $21,914.22/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CGHM + PFE for your $10,000?

CGHM: 50%PFE: 50%
100% PFE50/50100% CGHM
Portfolio after 10yr
$37.5K
Annual income
$13,368.00/yr
Blended yield
35.61%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

CGHM
No analyst data
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CGHM buys
0
PFE buys
0
No recent congressional trades found for CGHM or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCGHMPFE
Forward yield3.75%6.13%
Annual dividend / share$0.95$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$25.5K$49.6K
Annual income after 10y$477.28$26,258.71
Total dividends collected$4.3K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CGHM vs PFE ($10,000, DRIP)

YearCGHM PortfolioCGHM Income/yrPFE PortfolioPFE Income/yrGap
1$11,075$375.07$9,153$693.39+$1.9KCGHM
2$12,239$388.21$8,593$849.25+$3.6KCGHM
3$13,496$400.93$8,336$1,066.78+$5.2KCGHM
4$14,854$413.21$8,437$1,384.80+$6.4KCGHM
5$16,319$425.03$9,013$1,875.40+$7.3KCGHM
6$17,898$436.40$10,306$2,680.72+$7.6KCGHM
7$19,598$447.30$12,820$4,101.38+$6.8KCGHM
8$21,427$457.75$17,673$6,826.70+$3.8KCGHM
9← crossover$23,395$467.74$27,543$12,591.86$4.1KPFE
10$25,510$477.28$49,560$26,258.71$24.1KPFE

CGHM vs PFE: Complete Analysis 2026

CGHMStock

To provide a high level of current income exempt from regular federal income tax.Distinguishing Characteristics Primarily invests in state, municipal and public authority bonds and notes. Normally, at least 80% of assets will be invested in tax-exempt securities. (May invest up to 100% of assets in bonds whose interest may be subject to the alternative minimum tax.) The fund will normally invest at least 60% of assets in debt securities rated BBB+ or below or Baa1 or below at the time of purchase by Nationally Recognized Statistical Rating Organizations designated by the fund’s investment adviser, or unrated but determined by the fund’s investment adviser to be of equivalent quality.Typically, the fund will be invested in intermediate- to long-term securities.

Full CGHM Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this CGHM vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CGHM vs SCHDCGHM vs JEPICGHM vs OCGHM vs KOCGHM vs MAINCGHM vs JNJCGHM vs MRKCGHM vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.